EUVIMEDOpdag EUVIMED
Crossref

Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content

Yair Kaufman, K C Hunt, Gabriel Hale, Matthew McClure, David Latulippe, Madhavi Sivan, Jack Wilson, Rachel Dorin, Yury Agroskin, Marty Siwak, Daniele Gerion

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28420 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2024. Written by Yair Kaufman and 10 co-authors. Institution: TeraPore Technologies, South San Francisco, California, USA. Major MEDLINE topics: Antibodies, Monoclonal, Membranes, Artificial. Cited 8 times so far (Crossref); 31 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Membrane fouling by monoclonal antibodies (mAbs) is one of the main challenges in virus‐filtration processes. Previous publications attributed membrane fouling to the presence of mAb aggregates in the solution, which block the membrane pores. This fouling mechanism can be solved by a prefilter; however, it was shown that there are mAbs that severely foul the membranes (reduce permeability by 90% and more) even after prefiltering the aggregates, while other mAbs foul the membrane weakly (reduce permeability by ~10% and less). Unfortunately, the differences between the fouling‐ and the nonfouling mAbs have never been convincingly explained. To get a deeper insight on these differences, we measured the fouling of chemically modified Isoprene‐Styrene‐4‐vinylpyridine (ISV) membranes (TeraPore Technologies) by 8 mAbs exhibiting different hydrophobicity and charge. The results show that mAb solutions with low concentration of aggregates foul ISV membranes via an adsorptive mechanism, and the adsorption is driven mainly by hydrophobic forces between the mAb and the membrane. The charge of the mAbs plays a secondary role in fouling. We want to emphasize that the conclusions pertain to ISV membranes; the insights presented in this paper can potentially be used to engineer new surface chemistries to mitigate fouling of other virus‐filtration and/or ultrafiltration membranes.

Subjects

MeSH terms (MEDLINE)

Antibodies, MonoclonalMembranes, ArtificialFiltrationVirusesBiofoulingUltrafiltrationAdsorption

Author keywords

membrane foulingmonoclonal antibodiesprotein adsorptionvirus filtration

Substances

Antibodies, MonoclonalMembranes, Artificial

Authors and institutions

  • TeraPore Technologies, South San Francisco, California, USA.
  • Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.

Cite

APA

Kaufman, Y., Hunt, K. C., Hale, G., McClure, M., Latulippe, D., Sivan, M., Wilson, J., Dorin, R., Agroskin, Y., Siwak, M., & Gerion, D. (2024). Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28420

Vancouver

Kaufman Y, Hunt KC, Hale G, McClure M, Latulippe D, Sivan M, et al. Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28420

BibTeX
@article{Kaufman2024,
  author = {Kaufman, Yair and Hunt, K C and Hale, Gabriel and McClure, Matthew and Latulippe, David and Sivan, Madhavi and Wilson, Jack and Dorin, Rachel and Agroskin, Yury and Siwak, Marty and Gerion, Daniele},
  title = {Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28420}
}
Start for free →